JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Using cdPCR, we identified a low-allele burden of JAK2 V617F subclone in a de novo CML patient, which expanded during TKI treatment, highlighting the potential of cdPCR in uncovering these hidden subclones.